Patents by Inventor Eric S. Lader

Eric S. Lader has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120270316
    Abstract: This specification relates to the field of molecular biology and provides novel methods and reagents for preserving and protecting the ribonucleic acid (RNA) content of samples from degradation prior to RNA isolation. This preservation may be accomplished without ultra-low temperature storage or disruption of the tissue.
    Type: Application
    Filed: April 23, 2012
    Publication date: October 25, 2012
    Applicant: APPLIED BIOSYSTEMS, LLC
    Inventor: Eric S. Lader
  • Patent number: 8178296
    Abstract: This specification relates to the field of molecular biology and provides novel methods and reagents for preserving and protecting the ribonucleic acid (RNA) content of samples from degradation prior to RNA isolation. This preservation may be accomplished without ultra-low temperature storage or disruption of the tissue.
    Type: Grant
    Filed: August 3, 2009
    Date of Patent: May 15, 2012
    Assignee: Applied Biosystems, LLC
    Inventor: Eric S. Lader
  • Publication number: 20100028852
    Abstract: This specification relates to the field of molecular biology and provides novel methods and reagents for preserving and protecting the ribonucleic acid (RNA) content of samples from degradation prior to RNA isolation. This preservation may be accomplished without ultra-low temperature storage or disruption of the tissue.
    Type: Application
    Filed: August 3, 2009
    Publication date: February 4, 2010
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventor: Eric S. Lader
  • Publication number: 20030114651
    Abstract: This specification relates to the field of molecular biology and provides novel methods and reagents for preserving and protecting the ribonucleic acid (RNA) content of samples from degradation prior to RNA isolation. This preservation may be accomplished without ultra-low temperature storage or disruption of the tissue.
    Type: Application
    Filed: January 30, 2003
    Publication date: June 19, 2003
    Inventor: Eric S. Lader
  • Patent number: 6528641
    Abstract: This specification relates to the field of molecular biology and provides novel methods and reagents for preserving and protecting the ribonucleic acid (RNA) content of samples from degradation prior to RNA isolation. This preservation may be accomplished without ultra-low temperature storage or disruption of the tissue.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: March 4, 2003
    Assignee: Ambion, Inc.
    Inventor: Eric S. Lader
  • Publication number: 20010016312
    Abstract: This specification relates to the field of molecular biology and provides novel methods and reagents for preserving and protecting the ribonucleic acid (RNA) content of samples from degradation prior to RNA isolation. This preservation may be accomplished without ultra-low temperature storage or disruption of the tissue.
    Type: Application
    Filed: January 26, 2001
    Publication date: August 23, 2001
    Applicant: Ambion, Inc.
    Inventor: Eric S. Lader
  • Patent number: 6204375
    Abstract: This specification relates to the field of molecular biology and provides a novel method and reagent for preserving and protecting the ribonucleic acid (RNA) content of tissue samples from degradation prior to RNA isolation. This preservation may be accomplished without ultra-low temperature storage or disruption of the tissue.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: March 20, 2001
    Assignee: Ambion, Inc.
    Inventor: Eric S. Lader
  • Patent number: 6057134
    Abstract: The invention relates to modified oligonucleotide primers used to adjust the amplification efficiency of an abundant target without affecting the amplification of other targets in a DNA synthesis reaction. The invention may be used in PCR.TM. or any other primer dependent DNA transcription technology.
    Type: Grant
    Filed: October 7, 1996
    Date of Patent: May 2, 2000
    Assignee: Ambion, Inc.
    Inventors: Eric S. Lader, Marianna Goldrick, Matthew Winkler